PBV Insights
Log In Get Started
Menu
Deals & Cases
23 Sep 2026

Kirkland & Ellis Advises ARCHIMED on Final Close of Oversubscribed €1.5 Billion MED IV Fund

"Kirkland & Ellis advised ARCHIMED on the final close of its MED IV fund at a €1.5 billion ($1.75 billion) hard cap. Launched in January 2026 with a €1.2 billion ($1.4 billion) target, the fund closed in under six months and was three times oversubscribed."

Kirkland & Ellis advised ARCHIMED, a global private equity specialist exclusively focused on healthcare, on the successful final close of the MED IV fund. The fund closed at its €1.5 billion ($1.75 billion) hard cap. Launched in January 2026 with an original target of €1.2 billion ($1.4 billion), the fund completed its raise in less than six months and was three times oversubscribed. The oversubscription reflected strong, sustained demand from both existing and new investors. Kirkland & Ellis represented ARCHIMED with a team composed by: Raphaël Bloch, Richard Watkins, Christopher Braunack and Sebastien Clisson, all investment funds lawyers.
Read the full story

Register for free to access daily news.

Register Free
Already registered? Login
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.